Clinical trials: Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
Locally Advanced Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma
First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma
This is an open label, first-in-man clinical trial to assess safety and tolerability of CEB-01 PLGA membrane in patients with recurrent or locally advanced retroperitoneal soft tissue sarcoma after surgery.
- Trial name
- NCT04619056
- Testing
- CEB-01 membrane loaded with SN-38
- Where
- 5 sites in Spain
- Volunteers
- 21 people
- Sponsor
- CEBIOTEX
Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma
This prospective, single-arm, open-label phase I study evaluates the safety and tolerability of intratumoral injection of tantalum nanoparticles (Ta-NPs) followed by radiotherapy in patients with locally recurrent retroperitoneal…
- Trial name
- NCT07578506
- Testing
- Ta-NPs (2% Tumor Volume), Ta-NPs (5% Tumor Volume), Ta-NPs (10% Tumor Volume)
- Where
- China
- Volunteers
- 9 people
- Sponsor
- West China Hospital
Retroperitoneal Sarcoma
Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery
To determine the safety of moderately hypofractionated radiation in the treatment of primary and locally recurrent RPS, based on the evaluation of acute radiation-related toxicity profile of each participant (30-day radiation…
- Trial name
- NCT06812052
- Testing
- Radiation Therapy, Hypofractionationed Radiation Therapy
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Brigham and Women's Hospital